Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Current Assets (2018 - 2025)

Dna X's Current Assets history spans 8 years, with the latest figure at $28.9 million for Q4 2025.

  • Quarterly results put Current Assets at $28.9 million for Q4 2025, down 10.12% from a year ago — trailing twelve months through Dec 2025 was $28.9 million (down 10.12% YoY), and the annual figure for FY2025 was $28.9 million, down 10.12%.
  • Current Assets for Q4 2025 was $28.9 million at Dna X, down from $30.3 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $47.5 million in Q3 2023 to a low of $26.9 million in Q1 2025.
  • The 5-year median for Current Assets is $33.8 million (2022), against an average of $35.3 million.
  • The sharpest move saw Current Assets crashed 43.04% in 2021, then surged 39.42% in 2023.
  • Year by year, Current Assets stood at $35.7 million in 2021, then increased by 22.26% to $43.6 million in 2022, then increased by 0.36% to $43.8 million in 2023, then decreased by 26.54% to $32.2 million in 2024, then decreased by 10.12% to $28.9 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $28.9 million, $30.3 million, and $27.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.